showed that about 40% of SF3B1 mutation MDS cases showed non-K700E mutations, and further classification studies found that only SF3B1 mutation MDS patients with involvement of K700E mutations had a good prognosis. Here, SF3B1 is linked to myelodysplastic syndrome.